Shares of Castle Biosciences, Inc. (CSTL) have gained 1.5% over the past four weeks to close the last trading session at $27.06, but there could still be a solid upside left in the stock if short ...

The best bed frames, however, go beyond mere aesthetics—they offer functionality, sustainability and versatility to boot. We chose Thuma’s “The Bed” as our pick for the best overall bed ...

Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma ...

Leerink Partners analyst Puneet Souda has maintained their bullish stance on CSTL stock, giving a Buy rating yesterday. Puneet Souda has given his Buy rating due to a combination of factors ...

Trump as president has always had an impulsive nature. In Round 2, it's appearing to play a big role in his policy agenda. The Latest Biden says America is better-positioned thanks to his foreign ...

Economist Steven Hamilton said the image showed “Australian policy failure in one picture”. “Informal markets, two ways,” he wrote. “Tax something into oblivion to create an informal market.